Tramadol is not as safe for older adults as many people assume. Once considered a gentler alternative to stronger opioids, tramadol carries a list of age-specific risks that have become clearer over the past decade, from hip fractures and delirium to dangerous drops in blood sugar and sodium. Its body stays in the system roughly 50 percent longer in people over 65, and it interacts badly with medications that older adults commonly take. Whether tramadol is appropriate depends heavily on the individual, but the blanket perception that it is a low-risk painkiller for aging patients deserves serious skepticism.
Why Tramadol Hits Harder in Older Bodies
Most drugs behave differently in a 75-year-old than in a 30-year-old, and tramadol is no exception. A pharmacokinetic study comparing elderly and young adults found that the average elimination half-life of tramadol was about 50 percent longer in the older group. The volume of distribution was roughly a third higher, and the rate at which the kidneys cleared the drug’s active metabolite was about 29 percent lower.1Drugs & Aging. Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects In plain terms, tramadol and its pain-relieving breakdown product hang around in an older person’s bloodstream much longer, meaning each dose has more time to accumulate and cause side effects.
This slower clearance is why geriatric dosing guidelines generally call for lower starting doses and longer intervals between them. The standard adult dose might be reasonable for a healthy 40-year-old, but in someone over 75 with even mildly reduced kidney function, that same dose can pile up over days, gradually increasing the risk of confusion, dizziness, and other adverse effects.
The Hip Fracture Problem
One of the most consequential risks for older tramadol users is hip fracture. This is not a theoretical concern. A meta-analysis of observational studies found that tramadol use raised the overall risk of hip fracture by about 32 percent compared to non-use. The risk was especially pronounced in men and in people under 65 with osteoarthritis.2PubMed. Association of tramadol use with risk of hip fractures in patients with osteoarthritis: A systematic review and meta-analysis of observational studies A separate large study of older adults with post-traumatic osteoarthritis found that those aged 60 to 70 had roughly double the hip fracture risk when using tramadol, and men faced a particularly steep increase.3PubMed Central. Tramadol May Increase Risk of Hip Fracture in Older Adults with Post-Traumatic Osteoarthritis
What makes these numbers striking is that tramadol performed worse than many common alternatives. A population-based cohort study found that tramadol users had a higher rate of hip fractures than people starting codeine, naproxen, ibuprofen, celecoxib, or etoricoxib. The gap was largest when comparing tramadol to NSAIDs: the fracture rate on tramadol was roughly 65 to 96 percent higher than on common anti-inflammatory drugs.4PubMed Central. Association of Tramadol Use With Risk of Hip Fracture The authors of that study explicitly called for a rethink of clinical guidelines that position tramadol as a safer first-line option.
The mechanism likely involves a combination of dizziness, sedation, and orthostatic hypotension, which is a sudden drop in blood pressure when standing up. All three increase fall risk, and in an older person with thinning bones, even a minor fall can result in a fracture.
Delirium and Confusion
Tramadol’s effects on the brain go beyond pain relief. A systematic review comparing opioids found that tramadol was associated with an increased risk of delirium, whereas morphine, fentanyl, oxycodone, and codeine were not, when compared against no opioid use at all.5PubMed Central. The Comparative Risk of Delirium with Different Opioids: A Systematic Review That finding surprised many clinicians who had assumed tramadol’s weaker opioid activity would translate into fewer cognitive side effects.
Delirium from tramadol can be subtle and long-lasting. A case report documented two elderly patients who experienced fluctuating confusion and cognitive problems for over two years before anyone identified tramadol as the cause. Their symptoms reversed only after the drug was stopped.6PubMed. Unrecognised long-lasting tramadol-induced delirium in two elderly patients. A case report Two years of avoidable cognitive decline is a sobering example of how easily tramadol-related delirium can be missed, especially when the patient already has age-related memory concerns that make it easy to chalk up confusion to “getting older.”
If you or a family member started tramadol around the same time cognitive difficulties appeared, that timing is worth mentioning to a doctor. The connection is easy to overlook but straightforward to test by discontinuing the medication under supervision.
Blood Sugar Drops and Sodium Imbalances
Two metabolic risks distinguish tramadol from most other painkillers: hypoglycemia and hyponatremia. Neither is widely known among patients, but both can be serious.
A study comparing tramadol to codeine found that starting tramadol was associated with a roughly 2.5-fold increase in the risk of hospitalization for low blood sugar. In the first 30 days of use, the risk was even steeper, nearly quadrupling in some analyses.7PubMed. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain Frail, elderly patients are especially vulnerable to this effect, and rapid dose increases make it worse.8JCEM Case Reports. Insulinoma Mimic: Tramadol-induced Hypoglycemia In older adults who are already managing diabetes with insulin or sulfonylureas, adding tramadol can tip blood sugar dangerously low.
Hyponatremia, a dangerous drop in blood sodium levels, is the other metabolic concern. Tramadol can trigger the release of antidiuretic hormone, which causes the body to retain too much water and dilutes sodium in the blood.9PubMed Central. Risk of Hyponatremia after Tramadol/Acetaminophen Single-Pill Combination Therapy: A Real-World Study Based on the OMOP–CDM Database One study found that tramadol use roughly doubled the risk of hospitalization for hyponatremia compared to codeine, and in a more restricted analysis, the risk was over three times higher.10The American Journal of Medicine. Tramadol and Risk of Hyponatremia in Older Patients Newly starting tramadol or codeine appears to be the highest-risk window. A Swedish population study confirmed that recently initiated treatment with either drug carried the strongest association with severe hyponatremia.11PubMed. Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study
Symptoms of low sodium include nausea, headache, confusion, and in severe cases, seizures or coma. In an older person, these symptoms overlap with many other conditions, making them easy to misattribute. Routine blood work during the first few weeks of tramadol use can catch the problem early.
Dangerous Drug Interactions
Tramadol is unusual among painkillers because it acts on multiple brain systems at once. Beyond its opioid effects, it blocks the reuptake of serotonin and norepinephrine, functioning partly like an antidepressant. This dual action creates interaction risks that other opioids do not carry to the same degree.
The most widely discussed interaction is with antidepressant medications, which many older adults take. When tramadol is combined with drugs that raise serotonin levels, particularly SSRIs or SNRIs, the risk of serotonin syndrome and seizures goes up. Both adverse reactions can occur during tramadol use alone but are much more likely when it is combined with antidepressants.12PubMed Central. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants A study of older nursing home residents found that combining tramadol with antidepressants that inhibit the CYP2D6 liver enzyme was associated with a higher rate of seizures compared to combining it with antidepressants that do not affect that enzyme.13PubMed Central. Risk of Seizure Associated With Concomitant Use of Tramadol and Antidepressants in Older Nursing Home Residents Common CYP2D6 inhibitors include fluoxetine (Prozac), paroxetine (Paxil), and bupropion (Wellbutrin).
Respiratory depression, though less common with tramadol than with stronger opioids, is another concern. An analysis of the global pharmacovigilance database found that people taking tramadol alongside benzodiazepines, other opioids, antidepressants, or CYP2D6 inhibitors were overrepresented among respiratory depression cases.14PubMed Central. Risk Factors for Respiratory Depression Associated with Tramadol Based on the Global Pharmacovigilance Database (VigiBase) Many older adults take benzodiazepines for sleep or anxiety, making this a practical danger rather than a rare edge case.
How Your Genetics Change Tramadol’s Effects
Tramadol itself is actually a prodrug. It needs to be converted by the CYP2D6 liver enzyme into its active form before it provides significant pain relief. People vary widely in how efficiently their bodies perform this conversion based on inherited genetic differences. A study of different CYP2D6 genotypes found that people with intermediate metabolism experienced more side effects than those with extensive (normal) metabolism, and those with extensive metabolism had more side effects than ultra-rapid metabolizers.15PubMed. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics
In practical terms, this means some people get little pain relief from tramadol but plenty of side effects from the parent compound, while others convert it so quickly that they are effectively getting a higher dose of opioid than intended. Neither extreme is ideal, and when you layer age-related changes in liver function on top of genetic variation, the resulting dose-response curve becomes hard to predict. Pharmacogenomic testing exists and is increasingly available, but it is rarely ordered before prescribing tramadol in routine practice.
Is Tramadol Actually Safer Than Other Painkillers?
For years, tramadol’s reputation as a “mild” opioid led clinicians to reach for it as a first option for older patients, especially those with osteoarthritis. The evidence now paints a more complicated picture.
A study of older adults after hip or knee replacement found that tramadol was associated with increased rates of serious adverse events compared to both oxycodone and hydrocodone. Compared to hydrocodone, the rate of serious adverse events was about 34 to 40 percent higher among tramadol users. The authors concluded that tramadol does not have a superior safety profile and should not be preferentially prescribed to older adults who have not previously taken opioids.16PubMed Central. Comparative safety of tramadol and other opioids following total hip and knee arthroplasty A broader study of older adults with osteoarthritis found that tramadol use was tied to increased risks of emergency room visits, falls, fractures, cardiovascular hospitalizations, and in new users, mortality.17PubMed Central. Safety Events Associated with Tramadol Use Among Older Adults with Osteoarthritis
Tramadol does have at least one advantage over some alternatives. A large retrospective study found it carried a lower risk of severe constipation compared to codeine.18PubMed Central. Comparative risk of severe constipation in patients treated with opioids for non-cancer pain: a retrospective cohort study in Northwest England And one trial in elderly knee osteoarthritis patients found that a tramadol-acetaminophen combination provided better pain scores than NSAIDs, though nausea, vomiting, and constipation were common, affecting roughly a third to half of the tramadol group.19Journal of Rheumatic Diseases. Comparison of Effectiveness and Safety of Tramadol/Acetaminophen and Non-steroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Knee Osteoarthritis in Elderly Patients So the calculus is not straightforward: tramadol may manage pain well and spare the gut somewhat, but it trades those benefits for risks to the brain, bones, blood sugar, and sodium levels that other options do not carry to the same extent.
The American Geriatrics Society’s Beers Criteria, which is the most widely used list of medications considered potentially inappropriate for older adults, includes opioids broadly and is used by clinicians, researchers, and regulators as a guide for cautious prescribing.20PubMed Central. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults Being on this list does not mean a drug can never be used, but it does mean extra caution and monitoring are expected.
Dosing Principles for Older Adults
When tramadol is prescribed for someone over 65, standard practice calls for starting at the lowest effective dose. For immediate-release tramadol, this typically means 25 mg once or twice daily, titrated upward slowly rather than starting at the 50 mg dose used for younger adults. Extended-release formulations, given the longer half-life in older bodies, demand even more conservative initiation. The general principle is “start low, go slow,” with dose adjustments no more frequent than every few days, and ideally a maximum daily dose that stays well below what would be considered normal in a younger patient.
Kidney and liver function should be assessed before prescribing, since both affect tramadol clearance. In people with significantly impaired kidney function, dosing intervals need to be extended. The same applies to liver impairment, which can slow the conversion of tramadol into its active metabolite and also delay elimination of the parent drug.
Blood glucose and sodium levels warrant monitoring in the first 30 days, which is the highest-risk window for both hypoglycemia and hyponatremia. If an older patient is on antidepressants, the prescriber needs to weigh the seizure and serotonin syndrome risks explicitly, not simply assume that tramadol’s “mild” reputation provides adequate reassurance.
Stopping Tramadol Safely
If the decision is made to discontinue tramadol, the process itself requires care. Tramadol produces physical dependence even at therapeutic doses, and abrupt cessation can trigger withdrawal symptoms including anxiety, sweating, insomnia, and pain rebound. In older adults specifically, a study of opioid tapering found that both rapid tapering and dose escalation were significantly associated with mental health crises compared to staying on a steady dose. Rapid tapering raised the odds of a mental health crisis by about 45 percent.21PubMed Central. Opioid tapering and mental health crisis in older adults
The lesson is that stopping tramadol should be gradual, with dose reductions spread over weeks or months rather than days. A common approach involves reducing the daily dose by roughly 10 percent every one to two weeks, monitoring for withdrawal symptoms and pain flares along the way. If the patient’s pain condition still requires treatment, transitioning to a non-opioid strategy before or during the taper improves the chances of a smooth discontinuation. Physical therapy, topical anti-inflammatories, and acetaminophen are among the alternatives that avoid the systemic risks tramadol carries, though none is a perfect substitute for every patient.
Tramadol’s unusual pharmacology, straddling the line between opioid and antidepressant, means its withdrawal syndrome can include atypical features not seen with other opioids, such as hallucinations, panic attacks, and severe anxiety. Clinicians and caregivers should be aware of this broader symptom profile rather than watching only for the classic opioid withdrawal signs of sweating and restlessness.